XML 39 R27.htm IDEA: XBRL DOCUMENT v3.25.3
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK OPTION GRANTED

During the three and nine months ended September 30, 2025 and 2024, the Company granted options to purchase the number of shares of the Company’s common stock set forth in the table below (in thousands):

 

                 
   Three months ended September 30,   Nine months ended September 30, 
   2025   2024   2025   2024 
Stock options granted   12    -    137    168 
SCHEDULE OF WEIGHTED-AVERAGE ASSUMPTIONS USED FOR STOCK OPTIONS GRANTED

The following weighted-average assumptions were used for stock options granted during the three and nine months ended September 30, 2025 and 2024:

 

                 
   Three months ended September 30,   Nine months ended September 30, 
   2025   2024   2025   2024 
Weighted average risk-free rate   4.23%        -    4.38%   4.45%
Weighted average volatility   130.22%   -    117.25%   97.91%
Dividend yield   0.00%   -    0%   0.00%
Expected term   10.0 years    -    6.66 years    5.85 years 
SCHEDULE OF WEIGHTED AVERAGE GRANT-DATE FAIR VALUE OF STOCK OPTIONS

The per-share weighted average grant-date fair value of stock options granted during the three and nine months ended September 30, 2025 and 2024 were as follows:

 

    2025   2024   2025   2024 
    Three months ended September 30,   Nine months ended September 30, 
    2025   2024   2025   2024 
Weighted average grant date fair value   $1.29   $-   $4.02   $21.55 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

For the three and nine months ended September 30, 2025 and 2024, the Company recognized stock-based compensation expense as follows (in thousands):

 

   2025   2024   2025   2024 
   Three months ended September 30,   Nine months ended September 30, 
   2025   2024   2025   2024 
Research and development  $9   $13   $40   $74 
General and administrative   284   $392    1,123    1,036 
Total  $293   $405   $1,163   $1,110